Oct. 13, 2011
(Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will release its third-quarter 2011 financial results before the market opens on
Tuesday, October 25
and host a conference call for investors and analysts that day at
9:00 a.m. ET
On the call, President and Chief Executive Officer
and Executive Vice President and Chief Financial Officer
will discuss Cynosure's financial results, as well as the company's business outlook and strategy.
Those who wish to listen to the conference call webcast should visit the "Investor Relations" section of the company's website at
. The live call also can be accessed by dialing (877) 407-5790 or (201) 689-8328. If you are unable to listen to the live call, the webcast will be archived on the company's
About Cynosure, Inc.
develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to
treat vascular and pigmented lesions
rejuvenate the skin
liquefy and remove unwanted fat through laser lipolysis
reduce the appearance of cellulite
include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit
Vice President Sharon Merrill Associates, Inc. 617-542-5300
SOURCE Cynosure, Inc.